Elie Nuwayser
Principal investigator.
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
1991First federal award
$6.0MFederal grants as PI32 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
32 awards · $6.0M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 1, 2002 | NIH | SBIR/STTR Phase II Transdermal Buprenorphine for Opiate Antagonist Therapy | $444K | — |
| Apr 5, 2002 | NIH | SBIR/STTR Phase I Buprenorphine Microcapsules for Heroin Addiction | $100K | — |
| Apr 1, 2001 | NIH | SBIR/STTR Phase I A 30-DAY INJECTION FOR TREATMENT OF URINARY INCONTINENCE | $100K | — |
| Sep 30, 1999 | NIH | SBIR/STTR Phase I EVALUATION OF A 24 HOUR MICROBICIDE VAGINAL SUPPOSITORY | $189K | — |
| Jul 6, 1998 | NIH | NIH N43 SBIR PHASE I--MEDICATIONS DEVELOPMEN-DEPOT NALMEFENE | $100K | — |
| Jul 6, 1998 | NIH | NIH N43 SBIR PHASE I--MEDICATIONS DEVELOPMENT--DOSE RESPONSE | $100K | — |
| Jun 1, 1998 | NIH | SBIR/STTR Phase I BIODEGRADABLE GUIDES FOR PERIPHERAL NERVE REGENERATION | $100K | — |
| Apr 1, 1998 | NIH | SBIR/STTR Phase I ONE MONTH INJECTION FOR OSTEOPOROSIS | $100K | — |
| Sep 1, 1996 | NIH | SBIR/STTR Phase II BIODEGRADABLE MINERAL MICROSPHERE ADJUVANTS FOR VACCINES | $358K | — |
| Sep 1, 1996 | NIH | SBIR/STTR Phase II BIODEGRADABLE MINERAL MICROSPHERE ADJUVANTS FOR VACCINES | $306K | — |
| Sep 30, 1995 | NIH | SBIR/STTR Phase II INJECTABLE MICROCAPSULE FOR ESTROGEN REPLACEMENT THERAPY | $25K | — |
| Sep 30, 1995 | NIH | SBIR/STTR Phase II INJECTABLE MICROCAPSULE FOR ESTROGEN REPLACEMENT THERAPY | $239K | — |
| Sep 1, 1995 | NIH | SBIR/STTR Phase I BIODEGRADABLE BONE MATRIX FOR PEPTIDE DELIVERY | $100K | — |
| Sep 1, 1995 | NIH | SBIR/STTR Phase I BIODEGRADABLE ANTIBIOTIC BEADS FOR OSTEOMYLETIS | $80K | — |
| Aug 1, 1995 | NIH | SBIR/STTR Phase II DEVELOPMENT OF A NALTREXONE MICROCAPSULE INJECTION | $321K | — |
| Aug 1, 1995 | NIH | SBIR/STTR Phase II DEVELOPMENT OF A NALTREXONE MICROCAPSULE INJECTION | $272K | — |
| Sep 30, 1993 | NIH | NIH N44 SUPPOSITORIES FOR RAPID ANTI-EPILEPTIC DELIVERY OF DIAZE | $251K | — |
| Sep 30, 1993 | NIH | NIH N44 SUPPOSITORIES FOR RAPID ANTIEPILEPTIC DELIVERY | $241K | — |
| Sep 20, 1993 | NIH | SBIR/STTR Phase I INJECTABLE MICROCAPSULE FOR ESTROGEN REPLACEMENT THERAPY | $50K | — |
| Sep 1, 1993 | NIH | SBIR/STTR Phase I DEVELOPMENT OF A NALTREXONE MICROCAPSULE INJECTION | $50K | — |
| Sep 30, 1992 | NIH | NIH N01 DEVELOPMENT AND TESTING OF NEW SPERMICIDES | $48K | — |
| Sep 30, 1992 | NIH | NIH N01 DEVELOPMENT AND TESTING OF NEW SPERMICIDES | $55K | — |
| Sep 30, 1992 | NIH | NIH N01 DEVELOPMENT AND TESTING OF NEW SPERMICIDES | $99K | — |
| Sep 30, 1992 | NIH | NIH N01 DEVELOPMENT AND TESTING OF NEW SPERMICIDES | $232K | — |
| Sep 30, 1992 | NIH | NIH N01 DEVELOPMENT AND TESTING OF NEW SPERMICIDES | $223K | — |
| Apr 1, 1992 | NIH | SBIR/STTR Phase I TESTOSTERONE MICROCAPSULES FOR MALE CONTRACEPTION | $50K | — |
| Apr 1, 1992 | NIH | SBIR/STTR Phase II TESTOSTERONE MICROCAPSULES FOR MALE CONTRACEPTION | $331K | — |
| Apr 1, 1992 | NIH | SBIR/STTR Phase II TESTOSTERONE MICROCAPSULES FOR MALE CONTRACEPTION | $408K | — |
| Aug 1, 1991 | NIH | SBIR/STTR Phase II ESTROGEN-PROGESTIN PATCH FOR ESTROGEN REPLACEMENT | $241K | — |
| Aug 1, 1991 | NIH | SBIR/STTR Phase II ESTROGEN-PROGESTIN PATCH FOR ESTROGEN REPLACEMENT | $258K | — |
| Aug 1, 1991 | NIH | SBIR/STTR Phase II DEVELOPMENT AND TESTING OF A NEW SPERMICIDE SUPPOSITORY | $244K | — |
| Aug 1, 1991 | NIH | SBIR/STTR Phase II DEVELOPMENT AND TESTING OF A NEW SPERMICIDE SUPPOSITORY | $255K | — |
Peer ranks
Federal funding#46
Awards as PI#3
Patents#27
Companies
No tracked company linked yet.
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.